Clarus Therapeutics Holdings Inc. (CRXT) - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Clarus Therapeutics Holdings Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-04-20
Sale(A)
2022-04-25
5:17 pm
Clarus Therapeutics Holdings Inc.CRXTTHOMAS MCNERNEY & PARTNERS LP
TMP ASSOCIATES LP
TMP Nominee LLC
Thomas McNerney & Partners LLC
Thomas McNerney & Partners II L.P.
TMP Associates II LP
TMP Nominee II LLC
Thomas McNerney & Partners II LLC
THOMAS JAMES E
10% Owner
3,752,912$2.53$9,494,8673,528
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-07
Option Award
2022-06-09
8:06 pm
N/A
2032-06-06
Clarus Therapeutics Holdings Inc.CRXTPRYGOCKI MARK A SR
Director
6,727$010,571
(Direct)
View
2022-06-07
Option Award
2022-06-09
8:04 pm
N/A
2032-06-06
Clarus Therapeutics Holdings Inc.CRXTMurphy Kimberly M
Director
6,727$010,571
(Direct)
View
2022-06-07
Option Award
2022-06-09
8:02 pm
N/A
2032-06-06
Clarus Therapeutics Holdings Inc.CRXTAmory John Kenneth
Director
6,727$010,571
(Direct)
View
2022-06-07
Option Award
2022-06-09
8:02 pm
N/A
2032-06-06
Clarus Therapeutics Holdings Inc.CRXTHernandez Joseph
Director
6,727$01,313,071
(Direct)
View
2022-06-07
Option Award
2022-06-09
8:00 pm
N/A
2032-06-06
Clarus Therapeutics Holdings Inc.CRXTCermak Elizabeth
Director
6,727$010,571
(Direct)
View
2022-04-25
Other
2022-04-27
4:09 pm
N/A
N/A
Clarus Therapeutics Holdings Inc.CRXTHernandez Joseph
Director
1,302,500$07,226,344
(Indirect)
View
2022-04-25
Option Award
2022-04-27
4:09 pm
2021-09-09
2026-09-09
Clarus Therapeutics Holdings Inc.CRXTHernandez Joseph
Director
3,445,000$17,226,344
(Direct)
View
2021-12-12
Option Award
2021-12-14
7:03 pm
N/A
2031-12-11
Clarus Therapeutics Holdings Inc.CRXTPRYGOCKI MARK A SR
Director
13,454$013,454
(Direct)
View
2021-12-11
Option Award
2021-12-14
7:02 pm
N/A
2031-12-10
Clarus Therapeutics Holdings Inc.CRXTJaeger Frank
Chief Commercial Officer
101,500$0101,500
(Direct)
View
2021-12-12
Option Award
2021-12-14
7:00 pm
N/A
2031-12-11
Clarus Therapeutics Holdings Inc.CRXTCermak Elizabeth
Director
13,454$013,454
(Direct)
View
2021-12-12
Option Award
2021-12-14
7:00 pm
N/A
2031-12-11
Clarus Therapeutics Holdings Inc.CRXTAmory John Kenneth
Director
13,454$013,454
(Direct)
View
2021-12-12
Option Award
2021-12-14
7:00 pm
N/A
2031-12-11
Clarus Therapeutics Holdings Inc.CRXTDudley Robert E.
Chief Executive Officer
472,500$0477,066
(Direct)
View
2021-12-12
Option Award
2021-12-14
7:00 pm
N/A
2031-12-11
Clarus Therapeutics Holdings Inc.CRXTHernandez Joseph
Director
13,454$01,315,954
(Direct)
View
2021-12-11
Option Award
2021-12-14
7:00 pm
N/A
2031-12-10
Clarus Therapeutics Holdings Inc.CRXTPETERSON RICHARD D
Chief Financial Officer
195,300$0195,300
(Direct)
View
2021-12-11
Option Award
2021-12-14
7:00 pm
N/A
2031-12-10
Clarus Therapeutics Holdings Inc.CRXTBourne Steven A.
Chief Administrative Officer
101,500$0102,805
(Direct)
View
2021-12-12
Option Award
2021-12-14
7:00 pm
N/A
2031-12-11
Clarus Therapeutics Holdings Inc.CRXTMurphy Kimberly M
Director
13,454$013,454
(Direct)
View
(A) Indicate amendment filing.